Benchmark Vaccines Revenue and Competitors

BRAINTREE, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Benchmark Vaccines's estimated annual revenue is currently $3M per year.(i)
  • Benchmark Vaccines's estimated revenue per employee is $201,000

Employee Data

  • Benchmark Vaccines has 15 Employees.(i)
  • Benchmark Vaccines grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52.1M25912%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$112.8M5613%N/AN/A
#4
$21.9M10931%N/AN/A
#5
$34M16923%N/AN/A
#6
$59.5M296-4%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$7.8M3926%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

We are a contract manufacturing business focused on animal health vaccines. The scope of services includes process development through to full commercial manufacture of licenced vaccines in our EU GMP approved facility. Our current customers include the animal health divisions of several international pharmaceutical companies.\r\n\r\nPresence / History\r\n\r\nOur manufacturing operation was established in 1977 and was acquired in 2012 by Benchmark Vaccines Ltd (BVL) part of the Benchmark group of companies. We are located in Braintree in the United Kingdom less than 25km from London’s Stansted airport. \r\n\r\nA further BVL manufacturing facility is under development on the Edinburgh Science triangle Biocampus site, this is a 2500 square metre facility 20km from Edinburgh airport in the east of Scotland.\r\n\r\nExperience \r\n\r\nBenchmark Vaccines Ltd has broad experience and expertise in the development, manufacture and quality control of veterinary vaccines to EU GMP across all species including fish. Our operations are performed according to trie℠ – 3E principles (ethics, environment and economics) to help create and maintain a sustainable and healthy business.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Benchmark Vaccines News

2022-04-20 - Wealthy nations falter on global vaccine commitments

Daily COVID-19 vaccination totals for all residents in Massachusetts. Fully vaccinated number includes the second doses of Moderna and Pfizer,...

2022-04-20 - Global Vaccines Market Research Report 2022-2032: Focus ...

COVID-19 Crisis and Impact on Vaccines Demand. 3.1.2. COVID-19 Impact Benchmark with Previous Crisis. 3.1.3. Impact on Market Value (US$ Mn).

2022-04-17 - 20th Vaccination Week in the Americas aims to vaccinate ...

PAHO initiative is an opportunity to accelerate vaccination against COVID-19 ... The Americas region is a global benchmark in immunizations.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M1633%N/A
#2
$2.2M2222%N/A
#3
N/A24-4%N/A
#4
$4.1M260%N/A
#5
$3M260%N/A